Access Pharmaceuticals Inc. (ACCP)
-OTC Markets 0.45 0.00(0.00%) 12:38PM EDT
| Prev Close: | 0.45 |
|---|
| Open: | 0.46 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 7.00 |
|---|
| Beta: | 0.89 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.43 - 0.47 |
|---|
| 52wk Range: | 0.21 - 0.98 |
|---|
| Volume: | 179,568 |
|---|
| Avg Vol (3m): | 26,573 |
|---|
| Market Cap: | 11.20M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.16 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ACCESS PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Tue, May 21)
- Access Pharmaceuticals Reports First Quarter ResultsPR Newswire(Thu, May 16)
- ACCESS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- ACCESS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, May 9)
- Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual CongressPR Newswire(Mon, Apr 29)
- Access Pharmaceuticals CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Apr 3)
- Access Pharmaceuticals To Host Fourth Quarter And Fiscal Year Investor Call On Wednesday, April 3rd At 11:00am ETPR Newswire(Wed, Mar 20)
- ACCESS PHARMACEUTICALS INC Files SEC form 10-K, Annual ReportEDGAR Online(Tue, Mar 19)
- ACCESS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Nov 14)
- ACCESS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, FinanEDGAR Online(Fri, Oct 26)
- ACCESS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Thu, Oct 25)
- ACCESS PHARMACEUTICALS INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial ObligEDGAR Online(Tue, Sep 18)
- ACCESS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Aug 14)
- ACCESS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, May 29)
- ACCESS PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Tue, May 22)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.96 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Access Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients.
View More 
0.50%